Back to calendar
Cadrenal Therapeutics, Inc. (CVKD) Earnings
CVKD reports earnings on Thursday, November 5, 2026
earnings report
November 5, 2026 · Before Market Open
Q3 2026
Est. EPS: $-1.00
Actual EPS: $-1.14
EPS surprise: 19.72%
Company overview
Market Cap$6.0M
PriceUSD 1.67
EPS (TTM)-4.90
52-week high14.64
52-week low1.46
SectorHealth Technology
IndustryBiotechnology
Employees5